Formulations of thiomolybdate or thiotungstate compounds and uses thereof
OwnerRobert Ternansky, Brian Sullivan +1inventors
InventorsRobert Ternansky, Brian Sullivan, Andrew Chen
Life of this patent
Estimating the term…
Abstract
Formulations of thiomolybdate or thiotungstate derivatives, methods of making formulations of thiomolybdate or thiotungstate derivatives, solid dosage forms of thiomolybdate or thiotungstate analogues, methods of making solid dosage forms of thiomolybdate or thiotungstate analogues and methods of using solid dosage forms of thiomolybdate or thiotungstate derivatives to treat or prevent diseases associated with aberrant vascularization or aberrant angiogenesis, copper metabolism disorders neurodegenerative disorders and obesity are disclosed herein.
Claims20
A formulation comprising a thiomolybdate or thiotungstate compound, a pharmaceutically acceptable solvent and a matrix material.
The formulation of claim 37, wherein the buffer is Tris, lysine, arginine, glycine or triethanolamine.
A formulation comprising a dispersion of a thiomolybdate or thiotungstate compound, a pharmaceutically acceptable solvent and a matrix material.
A solid dosage form comprising a thiomolybdate or thiotungstate compound and a matrix material.
A solid dosage form consisting essentially of a thiomolybdate or thiotungstate compound and a matrix material.
A solid dosage form comprising a thiomolybdate or thiotungstate compound, a pharmaceutically acceptable solvent and a matrix material.
Dependencies are inferred from the claim text.